MedWatch

Lundbeck in secret settlement with generics-rival

Lundbeck has secretly agreed on an out-of-court settlement with one of its fiercest competitors, which secures the Danish company’s blockbuster drug against patent-related lawsuits. It comes on the back of EU-accusations concerning illegal deals for another of the company’s products.

There will be no more trials involving Lundbeck and Teva Pharmaceutical, the world’s largest manufacturer of generic medicine.

Teva and Lundbeck have agreed on a settlement, which shelves all current and future lawsuits involving Lundbeck and Teva Pharmaceutical Industries Ltd., as well as all subsidiaries of the company, the Danish company reveals to Medwatch.

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier